For the Inventor, By the Inventor

Enter assignee name

San Diego, CA, United States of America

Skye Pharma, Inc.

USPTO Granted Patents = 13

% Expired Patents = 7.7

Trademarks = 2

Forward Citations = 688

Loading Chart...

Loading Chart...

12 inventors (with patents filed for the assignee):

Mantripragada Bhima Sankaram (9 out of 10 patents)

Qiang Ye (5 out of 42 patents)

Sinil Kim (5 out of 26 patents)

4. Taehee Kim (2 out of 7 patents)

5. Rudolf Edgar Falk (1 out of 33 patents)

6. Sharad B Murdande (1 out of 2 patents)

7. Andres Gruber (1 out of 2 patents)

8. Nandini Katre (1 out of 2 patents)

9. Samuel Simon Asculai (1 out of 38 patents)

10. Alan L Russell (1 out of 1 patent)

11. Stephen B Howell (1 out of 18 patents)

12. Sharad Murdandi (1 out of 1 patent)

13 patents: Sort by Forward Citations

1. 6793938 - Biodegradable compositions for the controlled release of encapsulated substances (2004-09-21),

2. 6428529 - Epidural administration of therapeutic compounds with sustained rate of release (2002-08-06),

3. 6277413 - Biodegradable compositions for the controlled release of encapsulated substances (2001-08-21),

4. 6241999 - Method for producing liposomes with increased percent of compound encapsulated (2001-06-05),

5. 6193998 - Method for producing liposomes with increased percent of compound encapsulated (2001-02-27),

6. 6171613 - Method for producing liposomes with increased percent of compound encapsulated (2001-01-09),

7. 6159955 - Use of hyaluronic acid and a NSAID for the manufacture of a medicament (2000-12-12),

8. 6132766 - Multivesicular liposomes with controlled release of encapsulated (2000-10-17),

9. 6106858 - Modulation of drug loading in multivescular liposomes (2000-08-22),

10. 6071534 - Multivesicular liposomes with controlled release of active agents (2000-06-06),

11. 6045824 - Sustained-release liposomal anesthetic compositions (2000-04-04),

12. 5997899 - Method for producing liposomes with increased percent of compound (1999-12-07),

13. 5993850 - Preparation of multivesicular liposomes for controlled release of (1999-11-30),

Company Overview

Skye Pharma, Inc. is a biopharmaceutical company based in San Diego, California, specializing in the development and commercialization of innovative drug delivery systems. The company focuses on enhancing the therapeutic efficacy of existing medications through advanced formulation technologies. Skye Pharma's expertise spans various therapeutic areas, including oncology and pain management, leveraging its proprietary platforms to improve patient outcomes and streamline the drug development process.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

13 Patents

#411 in San Diego, CA

#5,661 in California

#23,854 in US

#45,081 in the World

San Diego, CA, United States of America

Skye Pharma, Inc.

Forward Citations = 688

12 inventors:

Mantripragada Bhima Sankaram (9 out of 10 patents)

Qiang Ye (5 out of 42 patents)

Sinil Kim (5 out of 26 patents)

4. Taehee Kim (2 out of 7 patents)

5. Rudolf Edgar Falk (1 out of 33 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Skye Pharma, Inc.. Retrieved from https://idiyas.com/company/skye-pharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…